Kazia Therapeutics' average one-year price target was raised to $21.42 per share from $19.38, a 10.53% increase. The update is analyst-driven and suggests improved expectations for the stock, but it is a routine estimate revision rather than a major catalyst.
Kazia Therapeutics' average one-year price target was raised to $21.42 per share from $19.38, a 10.53% increase. The update is analyst-driven and suggests improved expectations for the stock, but it is a routine estimate revision rather than a major catalyst.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
